Former Director Of FDA's 510(k) Staff To Join Trade Group MDMA

Article preview from "The Gray Sheet" - October 11, 2010

Heather Rosecrans, erstwhile director of FDA's 510(k) pre-market program staff, is joining the Medical Device Manufacturers Association to work on regulatory policy for the industry lobbying group.

Former Director Of FDA's 510(k) Staff To Join Trade Group MDMA

Article preview from "The Gray Sheet" - October 11, 2010

The longtime FDAer, who headed the agency's 510(k) program staff since 1992 and worked on the 510(k) and pre-market approval (PMA) staffs for decades, began settling in as vice president of regulatory affairs at MDMA early this month.

Rosecrans left FDA in mid-September (¹ 'The Gray Sheet' Sept. 20, 2010).

Shortly after, she announced she would join consulting firm Greenleaf Health, teaming up again with a number of her former FDA colleagues including ex-CDRH director Dan Schultz and ex-FDA Commissioner Andrew von Eschenbach (² 'The Gray Sheet' Oct. 4, 2010).

To  purchase this article online or get it FREE when you subscribe to "The Gray Sheet".

Plus:
To find out about more about more about Elsevier Business Intelligence's medical device publications and databases, multi-user access and/or advertising with Medical Devices Today, please contact Kristy Kennedy at (480) 985-9512